IRB Barcelona launches a scientific collaboration with Galapagos to identify and validate senolytic drug targets in inflammation and fibrosis

by IRB Barcelona - Instituto de Investigación Biomédica

​The Institute for Research in Biomedicine (IRB Barcelona) and the European biotech company Galapagos NV, based in Belgium, have established a scientific collaboration to identify and validate a ser...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream